OpGen Inc (OPGN) - Medical Equipment - Deals and Alliances Profile

OpGen Inc (OPGN) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME188486D
  • |
  • Pages: 62
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company's clinical laboratory services include high resolution microbial sequence analysis, swift detection and analysis of antibiotic resistance, and detection of pathogens in blood cultures. OpGen's develops products that includes QuickFISH, and PNA FISH products, Acuitas products, and Acuitas Lighthouse informatics. OpGen offers its surveillance products and customized screening services to healthcare providers to protect the hospital biome and optimize patient care. The company sells its products in the US and abroad. OpGen is headquartered in Gaithersburg, Maryland, the US.

OpGen Inc (OPGN)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

OpGen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

OpGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

OpGen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

OpGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

OpGen Inc, Medical Equipment, Deal Details 12

Venture Financing 12

AdvanDx Raises USD2.5 Million in Venture Financing 12

OpGen Raises USD1.2 Million in Venture Financing 13

Opgen Raises USD1 Million in Venture Financing 14

AdvanDx Raises USD 12 Million In Series B-1 Venture Financing 15

OpGen Raises USD 2 Million In Venture Financing 16

AdvanDx Raises USD 2 Million In Venture Financing 17

OpGen Raises Additional USD 2.6 Million In Series C Financing 18

OpGen Raises Additional USD1.4 Million in Venture Financing 20

Partnerships 21

OpGen Enters into Research Agreement with Merck 21

OpGen Enters into Co-Development Agreement with Fluidigm 22

OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 23

OpGen Enters Into Co-Development Agreement With In-Q-Tel 24

Equity Offering 25

OpGen Raises USD12 Million in Public Offering of Units 25

Opgen Raises USD10 Million in Public Offering of Units 27

OpGen to Raise upto USD11.5 Million in Public Offering of Shares 28

OpGen Raises USD10.4 Million in Private Placement of Shares and Warrants 29

OpGen Raises USD17 Million in IPO 31

Debt Offering 33

OpGen Raises USD0.5 Million in Debt Financing 33

OpGen Raises USD1.5 Million in Private Placement of 8% Notes 34

Acquisition 35

OpGen Acquires AdvanDx 35

OpGen Inc-Key Competitors 36

OpGen Inc-Key Employees 37

OpGen Inc-Locations And Subsidiaries 38

Head Office 38

Other Locations & Subsidiaries 38

Recent Developments 39

Financial Announcements 39

Aug 02, 2018: Opgen announces second quarter 2018 financial results 39

May 08, 2018: OpGen Announces First Quarter 2018 Financial Results 41

Mar 15, 2018: OpGen Announces Fourth Quarter and Full Year 2017 Financial Results 43

Nov 07, 2017: OpGen Reports 2017 Third Quarter Financial Results and Provides Business Update 45

Aug 08, 2017: OpGen Reports 2017 Second Quarter Financial Results and Provides Business Update 47

Apr 26, 2017: OpGen Announces 2017 First Quarter Financial Results 49

Mar 23, 2017: OpGen Announces 2016 Fourth Quarter and Year End Financial Results 50

Jan 26, 2017: OpGen Reports Preliminary Fourth Quarter and Full Year 2016 Financial Results 51

Corporate Communications 53

Apr 27, 2017: OpGen Appoints Tina S. Nova, Ph.D. to Board of Directors 53

Legal and Regulatory 54

Feb 05, 2018: OpGen Regains Compliance With Nasdaq Listing Requirements 54

Product News 55

Feb 01, 2018: OpGen Introduces New RUO Rapid Test for Infection Control and Surveillance Studies 55

Apr 12, 2017: OpGen to Present Antibiotic Resistance Prediction Data at 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 56

Feb 14, 2017: OpGen Presents Rapid Acuitas Genetic Test Data at Advances in Genome Biology and Technology Meeting 58

Other Significant Developments 59

Mar 13, 2018: OpGen Announces Collaborator in Verification Study for Acuitas Test 59

Feb 13, 2018: OpGen Strengthens Supplier Relationship to Use Industry-Leading Real-Time PCR Technology for New Acuitas Tests 60

Jun 15, 2017: OpGen's Acuitas Detection Technology Utilized in Publication Revealing Prevalence of CRE in Washington D.C. Healthcare Facilities 61

Appendix 62

Methodology 62

About GlobalData 62

Contact Us 62

Disclaimer 62

List of Figures

OpGen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

OpGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

OpGen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

OpGen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

OpGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

OpGen Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

List of Tables

OpGen Inc, Medical Equipment, Key Facts, 2017 2

OpGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

OpGen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

OpGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

OpGen Inc, Deals By Market, 2012 to YTD 2018 9

OpGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

AdvanDx Raises USD2.5 Million in Venture Financing 12

OpGen Raises USD1.2 Million in Venture Financing 13

Opgen Raises USD1 Million in Venture Financing 14

AdvanDx Raises USD 12 Million In Series B-1 Venture Financing 15

OpGen Raises USD 2 Million In Venture Financing 16

AdvanDx Raises USD 2 Million In Venture Financing 17

OpGen Raises Additional USD 2.6 Million In Series C Financing 18

OpGen Raises Additional USD1.4 Million in Venture Financing 20

OpGen Enters into Research Agreement with Merck 21

OpGen Enters into Co-Development Agreement with Fluidigm 22

OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 23

OpGen Enters Into Co-Development Agreement With In-Q-Tel 24

OpGen Raises USD12 Million in Public Offering of Units 25

Opgen Raises USD10 Million in Public Offering of Units 27

OpGen to Raise upto USD11.5 Million in Public Offering of Shares 28

OpGen Raises USD10.4 Million in Private Placement of Shares and Warrants 29

OpGen Raises USD17 Million in IPO 31

OpGen Raises USD0.5 Million in Debt Financing 33

OpGen Raises USD1.5 Million in Private Placement of 8% Notes 34

OpGen Acquires AdvanDx 35

OpGen Inc, Key Competitors 36

OpGen Inc, Key Employees 37

OpGen Inc, Subsidiaries 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

OpGen Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17980
Site License
USD 500 INR 35960
Corporate User License
USD 750 INR 53940

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com